KCT0003497招募中未知
Efficacy and safety of Rubus occidentalis extract on serum cholesterol; A 12 week, randomized, double-blind, placebo-controlled clinical trial
Berry&Bio Food Research Institue0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •200 mg/dl = cholesterol = 249 mg/dl
- •or 130 = LDL-cholesterol = 170 mg/dl
排除标准
- •1) treatment with hypolipidemic drugs within the past 3 months
- •2) those who receive treatment, rehabilitation, or inpatient treatment for heart disease or central nervous system disease
- •3) Creatinine level more than 2 times the upper limit of the normal range
- •4) ALT or AST level more than 3 times the upper limit of the normal range
- •5) uncontrolled diabetes, hypertension, or thyroid disease
研究者
相似试验
尚未招募
不适用
Efficacy and Safety of Rubus occidentalis extract on antihypertensive effect; A 8 week, Randomized, Double-blind, Placebo-Controlled Clinical TrialDiseases of the circulatory systemKCT0001946The Catholic University of Korea, St. Vincent's Hospital100
已完成
Unknown
Clinical trial to evaluate the effect of Rubus occidentalis on andropause symptomsDiseases of the genitourinary systemKCT0008306Berry&Bio Food Research Institue30
招募中
不适用
Efficacy and safety of Orostachydis Herba extracts in immune function improvement : a single center, randomised, double blind, placebo-controlled, clinical trialKCT0002123Pusan National University Korean Medicine Hospital62
已完成
3 期
Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Prospective, Placebo Controlled, Randomized, double-blinded Parallel-Group Comparison for SuperiorityAcute Otitis Media (AOM)H65.0 und H66.0Upper respiratory tract infectionH65.0H66.0Acute serous otitis mediaAcute suppurative otitis mediaDRKS00004569Weber & Weber GmbH & Co. KGBiologische Arzneimittel311
进行中（未招募）
不适用
Does a herbal-based medicine compared with a placebo (dummy drug) reduce the number of episodes with middle ear infection?recurrent acute otitis mediaMedDRA version: 16.1Level: PTClassification code 10033078Term: Otitis mediaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10033079Term: Otitis media acuteSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-000341-13-DEWeber & Weber GmbH & Co. KG